卡瑞利珠单抗联合安罗替尼治疗中晚期肝癌的疗效和安全性
Efficacy and Safety of Camrelizumab Combined With Anlotinib in the Treatment of Intermediate-Advanced Liver Cancer
CAI Yu1 , ZHAO Chang-hai2 , LUO Li-qiong1
卡瑞利珠单抗联合安罗替尼治疗中晚期肝癌的疗效和安全性 |
|
蔡宇 |
Efficacy and Safety of Camrelizumab Combined With Anlotinib in the Treatment of Intermediate-Advanced Liver Cancer |
|
CAI Yu
|
| 136例肝癌患者风险评估分析和AFU生存分析 |
| |